Session » Clinical and Therapeutic Poster Breakout I

Date: Thursday, May 18, 2017

Time: 4:45PM-5:15PM

Meeting: 2017 Pediatric Rheumatology Symposium

Abstract Number: 11

Safety of Adalimumab ± Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA): STRIVE Registry

Abstract Number: 12

Use of Ultrasound to Determine Remission Status in Children with Juvenile Idiopathic Arthritis

Abstract Number: 13

Prevalence of Celiac Antibodies and IgA deficiency in Juvenile Idiopathic Arthritis

Abstract Number: 14

Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial

Abstract Number: 15

An Internet-based Self-management Program for Adolescents with Juvenile Idiopathic Arthritis – A Randomized Controlled Trial

« View all sessions from this meeting